The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea
2008

Impact of Mass Drug Administration on Filariasis in Papua New Guinea

Sample size: 972 publication 10 minutes Evidence: high

Author Information

Author(s): Gary J. Weil, Will Kastens, Melinda Susapu, Sandra J. Laney, Steven A. Williams, Christopher L. King, James W. Kazura, Moses J. Bockarie

Primary Institution: Washington University School of Medicine

Hypothesis

What is the effect of repeated rounds of mass drug administration on bancroftian filariasis in Papua New Guinea?

Conclusion

Mass drug administration significantly reduced filariasis infection rates and incidence in the study area.

Supporting Evidence

  • Three rounds of mass drug administration decreased microfilaremia rates from 18.6% to 1.3%.
  • Filarial antigenemia rates decreased from 47.5% to 17.1% after three rounds of MDA.
  • The mean compliance rate for MDA was 72.9% across the study.
  • Children under 11 years showed a more significant decrease in infection rates compared to older individuals.

Takeaway

Giving medicine to people in villages can help get rid of a disease caused by worms that are spread by mosquitoes.

Methodology

The study involved monitoring infection rates before and after three rounds of mass drug administration with diethylcarbamazine and albendazole.

Potential Biases

Potential bias in self-reported compliance rates for drug administration.

Limitations

The study may not fully represent all regions of Papua New Guinea due to its focus on specific villages.

Participant Demographics

Residents of rural villages near Madang, Papua New Guinea, with a focus on children and adults.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000344

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication